Toward minimally disruptive management of symptomatic endometriosis: reducing low-value care and the burden of treatment-Reference-Cited by-同舟云学术

Toward minimally disruptive management of symptomatic endometriosis: reducing low-value care and the burden of treatment

Published:2017-12-06 Issue:1 Volume:18 Page:1-4
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Vercellini Paolo¹²^ORCID,Frattaruolo Maria Pina¹²^ORCID,Buggio Laura¹²^ORCID

Affiliation:

1. Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy

2. Department of Health of Woman, Child, and Newborn, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca - devolved to Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2018.1411803

Reference21 articles.

1. Pelvic Endometriosis Diagnosed in an Entire Nation Over 20 Years

2. The direct and indirect costs associated with endometriosis: a systematic literature review

3. Endometriosis: Diagnosis and Management

4. Practice Bulletin No. 114: Management of Endometriosis

5. Treatment of pelvic pain associated with endometriosis: a committee opinion

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023;Facts, Views and Vision in ObGyn;2024-04

2. Towards comprehensive management of symptomatic endometriosis: beyond the dichotomy of medical versus surgical treatment;Human Reproduction;2024-01-10

3. Various types of adenomyosis and endometriosis: in search of optimal management;Fertility and Sterility;2023-05

4. Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?;Human Reproduction Open;2023-01-01

5. GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis?;International Journal of Molecular Sciences;2021-10-20